Literature DB >> 19520842

Heterogeneous nuclear ribonucleoprotein K represses the production of pro-apoptotic Bcl-xS splice isoform.

Timothée Revil1, Jordan Pelletier, Johanne Toutant, Alexandre Cloutier, Benoit Chabot.   

Abstract

The Bcl-x pre-mRNA is alternatively spliced to produce the anti-apoptotic Bcl-x(L) and the pro-apoptotic Bcl-x(S) isoforms. By performing deletion mutagenesis on a human Bcl-x minigene, we have identified a novel exonic element that controls the use of the 5' splice site of Bcl-x(S). The proximal portion of this element acts as a repressor and is located downstream of an enhancer. Further mutational analysis provided a detailed topological map of the regulatory activities revealing a sharp transition between enhancer and repressor sequences. Portions of the enhancer can function when transplanted in another alternative splicing unit. Chromatography and immunoprecipitation assays indicate that the silencer element interacts with heterogeneous ribonucleoprotein particle (hnRNP) K, consistent with the presence of putative high affinity sites for this protein. Finally, down-regulation of hnRNP K by RNA interference enhanced splicing to Bcl-x(S), an effect seen only when the sequences bound by hnRNP K are present. Our results therefore document a clear role for hnRNP K in preventing the production of the pro-apoptotic Bcl-x(S) splice isoform.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19520842      PMCID: PMC2755870          DOI: 10.1074/jbc.M109.019711

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  81 in total

1.  Bcl-xL is overexpressed in hormone-resistant prostate cancer and promotes survival of LNCaP cells via interaction with proapoptotic Bak.

Authors:  Carolina Castilla; Belén Congregado; David Chinchón; Francisco J Torrubia; Miguel A Japón; Carmen Sáez
Journal:  Endocrinology       Date:  2006-06-22       Impact factor: 4.736

2.  SAP155 Binds to ceramide-responsive RNA cis-element 1 and regulates the alternative 5' splice site selection of Bcl-x pre-mRNA.

Authors:  Autumn Massiello; James R Roesser; Charles E Chalfant
Journal:  FASEB J       Date:  2006-06-21       Impact factor: 5.191

3.  Landscape of the hnRNP K protein-protein interactome.

Authors:  Michał Mikula; Artur Dzwonek; Jakub Karczmarski; Tymon Rubel; Michał Dadlez; Lucjan S Wyrwicz; Karol Bomsztyk; Jerzy Ostrowski
Journal:  Proteomics       Date:  2006-04       Impact factor: 3.984

Review 4.  Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy.

Authors:  S Fulda; K-M Debatin
Journal:  Oncogene       Date:  2006-08-07       Impact factor: 9.867

5.  SRp30a (ASF/SF2) regulates the alternative splicing of caspase-9 pre-mRNA and is required for ceramide-responsiveness.

Authors:  Autumn Massiello; Charles E Chalfant
Journal:  J Lipid Res       Date:  2006-02-27       Impact factor: 5.922

6.  An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers.

Authors:  Philip J Smith; Chaolin Zhang; Jinhua Wang; Shern L Chew; Michael Q Zhang; Adrian R Krainer
Journal:  Hum Mol Genet       Date:  2006-07-06       Impact factor: 6.150

7.  Protein clusters associated with carcinogenesis, histological differentiation and nodal metastasis in esophageal cancer.

Authors:  Hiromitsu Hatakeyama; Tadashi Kondo; Kiyonaga Fujii; Yukihiro Nakanishi; Hoichi Kato; Satoshi Fukuda; Setsuo Hirohashi
Journal:  Proteomics       Date:  2006-12       Impact factor: 3.984

8.  An RNA map predicting Nova-dependent splicing regulation.

Authors:  Jernej Ule; Giovanni Stefani; Aldo Mele; Matteo Ruggiu; Xuning Wang; Bahar Taneri; Terry Gaasterland; Benjamin J Blencowe; Robert B Darnell
Journal:  Nature       Date:  2006-10-25       Impact factor: 49.962

9.  Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer.

Authors:  B Carpenter; M McKay; S R Dundas; L C Lawrie; C Telfer; G I Murray
Journal:  Br J Cancer       Date:  2006-09-05       Impact factor: 7.640

10.  RET oncoproteins induce tyrosine phosphorylation changes of proteins involved in RNA metabolism.

Authors:  L Gorla; M Cantù; F Miccichè; C Patelli; P Mondellini; M A Pierotti; I Bongarzone
Journal:  Cell Signal       Date:  2006-05-24       Impact factor: 4.315

View more
  39 in total

1.  TCERG1 regulates alternative splicing of the Bcl-x gene by modulating the rate of RNA polymerase II transcription.

Authors:  Marta Montes; Alexandre Cloutier; Noemí Sánchez-Hernández; Laetitia Michelle; Bruno Lemieux; Marco Blanchette; Cristina Hernández-Munain; Benoit Chabot; Carlos Suñé
Journal:  Mol Cell Biol       Date:  2011-12-12       Impact factor: 4.272

2.  Proteins associated with the exon junction complex also control the alternative splicing of apoptotic regulators.

Authors:  Laetitia Michelle; Alexandre Cloutier; Johanne Toutant; Lulzim Shkreta; Philippe Thibault; Mathieu Durand; Daniel Garneau; Daniel Gendron; Elvy Lapointe; Sonia Couture; Hervé Le Hir; Roscoe Klinck; Sherif Abou Elela; Panagiotis Prinos; Benoit Chabot
Journal:  Mol Cell Biol       Date:  2011-12-27       Impact factor: 4.272

3.  Direct recruitment of ERK cascade components to inducible genes is regulated by heterogeneous nuclear ribonucleoprotein (hnRNP) K.

Authors:  Michal Mikula; Karol Bomsztyk
Journal:  J Biol Chem       Date:  2011-01-13       Impact factor: 5.157

4.  Disruption of the VDAC2-Bak interaction by Bcl-x(S) mediates efficient induction of apoptosis in melanoma cells.

Authors:  M Plötz; B Gillissen; A M Hossini; P T Daniel; J Eberle
Journal:  Cell Death Differ       Date:  2012-06-15       Impact factor: 15.828

5.  Regulation of Mcl-1 alternative splicing by hnRNP F, H1 and K in breast cancer cells.

Authors:  Alison Tyson-Capper; Hannah Gautrey
Journal:  RNA Biol       Date:  2018-12-04       Impact factor: 4.652

6.  The Proto-oncogene PKCι regulates the alternative splicing of Bcl-x pre-mRNA.

Authors:  Jacqueline C Shultz; Ngoc Vu; Michael D Shultz; Mba-Uzoma U Mba; Brian A Shapiro; Charles E Chalfant
Journal:  Mol Cancer Res       Date:  2012-04-20       Impact factor: 5.852

7.  Group VIA Phospholipase A2 (iPLA2β) Modulates Bcl-x 5'-Splice Site Selection and Suppresses Anti-apoptotic Bcl-x(L) in β-Cells.

Authors:  Suzanne E Barbour; Phuong T Nguyen; Margaret Park; Bhargavi Emani; Xiaoyong Lei; Mamatha Kambalapalli; Jacqueline C Shultz; Dayanjan Wijesinghe; Charles E Chalfant; Sasanka Ramanadham
Journal:  J Biol Chem       Date:  2015-03-11       Impact factor: 5.157

8.  Heterogeneous nuclear ribonucleoproteins F and K mediate insulin inhibition of renal angiotensinogen gene expression and prevention of hypertension and kidney injury in diabetic mice.

Authors:  S Abdo; C-S Lo; I Chenier; A Shamsuyarova; J G Filep; J R Ingelfinger; S-L Zhang; J S D Chan
Journal:  Diabetologia       Date:  2013-04-23       Impact factor: 10.122

9.  Role and molecular mechanism of heterogeneous nuclear ribonucleoprotein K in tumor development and progression.

Authors:  Jing Lu; Feng-Hou Gao
Journal:  Biomed Rep       Date:  2016-03-29

10.  Starvation actively inhibits splicing of glucose-6-phosphate dehydrogenase mRNA via a bifunctional ESE/ESS element bound by hnRNP K.

Authors:  T J Cyphert; A L Suchanek; B N Griffith; L M Salati
Journal:  Biochim Biophys Acta       Date:  2013-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.